Junling Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Chronic Myeloid Leukemia

Top Venues

OncoTargets and therapy

Cancer management and research

Lung Cancer (Auckland, N.Z.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jinlian Zhu, Jie Chen, Wei Liu, Junling Zhang, Yulan Gu
Mutation of MET D1228N as an Acquired Potential Mechanism of Crizotinib Resistance in NSCLC with MET Y1003H Mutation. Lung Cancer (Auckland, N.Z.) 15 (2024)
Jinlian Zhu, Jie Chen, Wei Liu, Junling Zhang, Yulan Gu
Mutation of MET D1228N as an Acquired Potential Mechanism of Crizotinib Resistance in NSCLC with MET Y1003H Mutation. Lung Cancer (Auckland, N.Z.) 15 (2024)
Zhisheng Liu, Junling Zhang, Yunjie Ge, Mengli Huang, Ye Wang
Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report. Cancer management and research 15 (2023)
Zhisheng Liu, Junling Zhang, Yunjie Ge, Mengli Huang, Ye Wang
Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report. Cancer management and research 15 (2023)
Lili Chen, Junling Zhang, Na Yang, Ningping Tan, Di Meng, Fei Zhang, Yuyang Qi, Guangqi Wu, Zhenyu Li
A Unique Three-Way Variant Philadelphia Chromosome t(6;9;22)(p21.3;q34;q11.2) in a Newly Diagnosed Patient with Chronic Myeloid Leukemia Responded to Flumatinib. OncoTargets and therapy 15 (2022)
Ning Sun, Yan Zhuang, Junling Zhang, Shiqing Chen, Yuwen Dai, Renhong Guo
ALK Rearrangement in Small-Cell Lung Cancer and Durable Response to Alectinib: A Case Report. OncoTargets and therapy 14 (2021)
Gang Shen, Yinping Du, Jifang Shen, Junling Zhang, Xihua Xia, Mengli Huang, Wenxiang Shen
Clinical Impact of Switching to Ceritinib After Severe AEs Related to Crizotinib/Alectinib in a Novel PTH2R-ALK Fusion Lung Adenocarcinoma: A Case Report. OncoTargets and therapy 14 (2021)